PATENT CLAIM ANALYSIS

Application Number: 16432468
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-12
Patent Classification: ["514", "649000"]

Abstract:
5-HT receptor agonists are useful in the treatment of a variety of diseases. Provided herein are methods of treating and/or reducing the occurrence of respiratory depression caused by an opioid in a human patient or patient population using a 5-HT receptor agonist, such as, for example, a 5-HT4 agonist (e.g., fenfluramine). Methods of stimulating one or more 5-HT 4  receptors in the brain of a patient undergoing treatment with an opioid, wherein the patient is at risk of respiratory depression, by administering a 5-HT4 agonist (e.g., fenfluramine) to a subject in need thereof are provided. Pharmaceutical compositions for use in practicing the subject methods are also provided.

Claim (Index 22):
The method of  claim 18  wherein the 5-HT 4  agonist is fenfluramine.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 100.0
- Lexical Diversity: 1.84848
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11847835', '14942344', '14659472', '14950707', '15429516']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7377194697325272
- 35 USC 102 Novelty (BERT): 0.5089305231526529
- Combined Prediction Score: 0.7148405750745398
- Mean Citation Score: 233.9574
- Max Citation Score: 245.63568
- Similarity Product: 175.2939763318634

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test